Study guide

Paediatric asthma

AMC CAT MCQ Examination AMC Part 1

Track your progress as you read

Finished sections get a check mark.

1 Acute Coronary Syndromes & ECG Localization

ACS recognition and ECG localisation Reperfusion and infarction complications

2 Heart Failure, Cardiogenic Shock & Cardiac Arrhythmias

Heart failure assessment and treatment Arrhythmias and conduction emergencies

3 Systemic Hypertension & Peripheral Vascular Disease

Blood pressure and cardiovascular risk Secondary hypertension and arterial disease

4 Valvular Heart Disease, Infective Endocarditis & Pericarditis

Aortic and mitral valve disease Endocarditis and pericardial emergencies

5 Asthma & COPD Acute Flares and Maintenance

Asthma and COPD diagnosis and maintenance Acute asthma and COPD exacerbations

6 Pneumonia, pleural disease and respiratory failure

Pneumonia and infected pleural collections Pulmonary embolism, effusions and pneumothorax Respiratory failure, ARDS and sepsis

7 GI bleeding, bowel inflammation and malabsorption

GI bleeding assessment and resuscitation Varices, ulcers, reflux and lower GI bleeding IBD patterns and severe colitis assessment IBD treatment, coeliac disease and IBS

8 Chronic Liver Disease, Cirrhosis Complications & Acute Hepatitis

Cirrhosis diagnosis and prognosis Decompensation, viral hepatitis and surveillance

9 Diabetes, thyroid and adrenal disease

Diabetes diagnosis and ongoing care DKA, HHS and complication monitoring Thyroid disease assessment Thyroid emergencies and adrenal disease

10 Acute Kidney Injury, Chronic Kidney Disease & Fluid/Electrolyte Emergencies

AKI and chronic kidney disease Potassium and sodium emergencies

11 Anaemias, Inflammatory Arthropathies & Geriatric Comprehensive Assessment

Anaemia, bruising and blood disorders Arthritis, autoimmune disease and geriatric care

12 Evaluation of the Acute Abdomen, Peritonitis & Appendicitis

Abdominal pain, peritonitis and resuscitation Appendicitis diagnosis and treatment Perforation and mesenteric ischaemia

13 Small and Large Bowel Obstruction & Colorectal Surgical Pathology

Small bowel obstruction Colonic obstruction, volvulus and cancer recognition Colorectal care, diverticulitis and anorectal symptoms

14 Gallbladder Disease, Biliary Tract Infections & Acute Pancreatitis

Gallstones and biliary obstruction Cholangitis and pancreatitis diagnosis Pancreatitis severity and treatment

15 Advanced Trauma Life Support, Primary Survey & Life-Threatening Thoracic Injuries

Trauma primary survey and adjuncts Chest trauma and immediate threats

16 Traumatic Brain Injury, Intracranial Haemorrhage & Spinal Cord Clearance

Head injury, imaging and haemorrhage Herniation and spinal cord injury

17 Major Fractures, Joint Dislocations & Acute Compartment Syndrome

Fracture assessment and open injuries Compartment syndrome, dislocations and pelvic injury

18 Thermal Burns, Haemorrhagic Shock Resuscitation & Surgical Wound Care

Burn assessment and fluid resuscitation Bleeding shock, wound care and tetanus

19 Aortic Aneurysms & Acute Arterial Limb Ischaemia

Aneurysm recognition and planned care Ruptured aneurysm and acute limb ischaemia

20 Urological Emergencies, Testicular Torsion & Haematuria Investigation

Retention, stones and obstructed infection Scrotal pain and haematuria

21 Preoperative Risk Stratification & Postoperative Surgical Complications

Preoperative assessment and medicines Postoperative complications and prevention

22 Early Pregnancy Bleeding, Ectopic Pregnancy & Antenatal Screening

Miscarriage and ectopic pregnancy Antenatal screening and early-pregnancy comparisons

23 Hypertensive Disorders of Pregnancy & Medical Complications in Pregnancy

Pregnancy hypertension and preeclampsia Eclampsia, HELLP and antepartum bleeding

24 Intrapartum Monitoring, Postpartum Haemorrhage & Obstetric Emergencies

Labour physiology and CTG assessment CTG response and postpartum haemorrhage Obstetric emergencies and preterm birth

25 Abnormal Uterine Bleeding, Pelvic Pain & Endometriosis

Abnormal bleeding and structural causes Endometrial sampling and endometriosis PCOS diagnosis and long-term care

26 Contraception, Emergency Contraception & Pregnancy Termination

Contraceptive choice and missed pills Emergency contraception and abortion

27 Australian Cervical Screening Program & Gynaecological Malignancies

Cervical screening and cervical cancer Endometrial and ovarian cancer

28 Neonatal Resuscitation, Congenital Conditions & Neonatal Jaundice

Newborn resuscitation, Apgar and cyanosis Neonatal jaundice assessment Jaundice treatment and congenital screening

29 Developmental Milestones, Growth Charts & Failure to Thrive

Developmental milestones Regression, autism and support Faltering growth and developmental comparisons

30 The Limping Child, Septic Arthritis vs Transient Synovitis & Paediatric Hip Conditions

Limp assessment and septic-joint risk Joint-infection management and Perthes disease SUFE and paediatric hip comparisons

31 Croup, Bronchiolitis, Paediatric Asthma & Anaphylaxis

Croup Bronchiolitis Paediatric asthma Paediatric anaphylaxis

32 Evaluation of the Febrile Child, Sepsis & Meningococcal Disease

Febrile neonates and young infants Meningococcal disease and paediatric sepsis Bacterial meningitis and CSF interpretation Kawasaki disease and follow-up

33 Paediatric Surgical Abdomen, Dehydration & Child Protection / Non-Accidental Injury

Pyloric stenosis Intussusception and dehydration Child protection and injury assessment

34 The Mental State Examination & Suicide Risk Stratification

Mental state examination and psychotic symptoms Suicide formulation and mental health law

35 Major Depressive Disorder, Bipolar Affective Disorder & Mood Stabilisers

Depression assessment and treatment Serotonin toxicity and bipolar presentations Mood stabilisers and ECT

36 Generalised Anxiety, Panic Disorder, PTSD & Obsessive-Compulsive Disorder

Anxiety, panic and agoraphobia OCD and trauma-related disorders

37 Schizophrenia, Acute Psychosis & Antipsychotic Management

Psychosis assessment and antipsychotics Clozapine and severe adverse effects

38 Substance Use Disorders & Acute Withdrawal Syndromes

Substance disorders and alcohol withdrawal Wernicke disease, opioids and stimulants

39 Delirium vs Dementia, Perinatal Mood Disorders & Paediatric Psychiatry

Delirium and dementia assessment Cognitive behaviour, perinatal and childhood psychiatry

40 Medicare, PBS, AHPRA & Good Medical Practice Framework

Australian health services and Medicare PBS access and professional registration Professional boundaries and notifications

41 Informed Consent (Rogers v Whitaker), Mental Capacity & Involuntary Treatment

Consent, material risks and young people Capacity, refusal and substitute decisions

42 Patient Privacy, Confidentiality Exceptions & Mandatory Notifications

Privacy, disclosure and child reporting Driving fitness and threat disclosure

43 First Nations health and preventive care

First Nations health, determinants and cultural safety Community care, Item 715 and CTG medicines Immunisation and cancer screening entry points Screening pathways and primary CVD prevention

44 Epidemiological Metrics, Clinical Study Designs & Notifiable Communicable Diseases

Epidemiology, calculations, bias and surveillance

45 Neurological presentations

Stroke, TIA and focal weakness Headache, facial pain and vertigo Seizures, collapse and altered consciousness Numbness, movement disorders and generalised weakness

46 Musculoskeletal pain

Back, neck, bone and soft tissue pain

47 Eye presentations

Altered vision and retinal disease Red eye, ocular injury and discharge

48 Ear, nose, throat and oral health

Ear pain, hearing loss and tinnitus Nasal problems, neck lumps, hoarseness and dysphagia Toothache, mouth symptoms, dry mouth and halitosis

49 Skin, hair and nails

Rash, itch, infection and skin ulcers Skin lesions, hair loss and nail abnormalities

50 Breast health and feeding

Breast lumps, discharge and breastfeeding problems

51 Sexual and reproductive presentations

Genital symptoms, discharge and pelvic infection Menopause, prolapse and urinary symptoms Infertility and sexual dysfunction

52 Palliative care and carers

The dying patient, symptoms and carers

53 Eating disorders and personality care

Eating disorders, obesity and weight change Personality difficulties, self-harm and complex care

54 Sleep presentations

Insomnia, snoring and daytime sleepiness

55 Poisoning, resuscitation and environmental emergencies

Poisoning, toxidromes and antidote decisions Cardiopulmonary arrest, choking and emergency help Bites, stings, heat, cold and drowning

56 Communication, rights and professional practice

Communication, handover, errors and complaints Healthcare rights, inclusive care and equitable access Certificates, deaths, CPD and supervision Telehealth, images, prescribing and doctors' health

57 Genetics, research and donation

Genetic testing, research and organ donation

58 Travel, fever and outbreaks

Fever, travellers and outbreak response

Paediatric asthma

Key Takeaways Explain This Topic AI

Salbutamol through a spacer is suitable for many paediatric attacks.

A silent chest or exhaustion requires urgent escalation.

Clinical improvement alone is insufficient without a safe discharge plan.

Last updated: October 2026

Paediatric Acute Asthma

Asthma is the most common chronic respiratory disorder of childhood in Australia. Acute exacerbations result from acute airway smooth muscle bronchospasm, mucosal oedema, and hypersecretion of viscous mucus.

Preschool Wheeze Phenotypes (Children Under 5 Years)

Viral-Induced Wheeze (Episodic Wheeze) : Wheezing episodes occur exclusively in association with acute viral upper respiratory tract infections, with complete absence of cough or wheeze between viral episodes. Usually resolves by early school age.

Multi-Trigger Wheeze : Wheezing occurs both during viral infections and in response to interval triggers (cold air, vigorous exercise, laughter, aeroallergens, emotional distress). Strongly linked to personal or family history of atopic eczema, allergic rhinitis, and elevated IgE; carries a high likelihood of persistent childhood asthma.

Acute Severity Assessment (Australian National Asthma Council Guidelines)

Physical Activity : Mild / Moderate Exacerbation: Ambulatory, playful, alert; Severe Exacerbation: Agitated, prefers sitting upright; Life-Threatening Exacerbation: Lethargic, confused, exhausted

Speech Capacity : Mild / Moderate Exacerbation: Speaks in sentences or phrases; Severe Exacerbation: Speaks only in single words; Life-Threatening Exacerbation: Unable to speak or cry

Respiratory Rate : Mild / Moderate Exacerbation: Mildly to moderately increased; Severe Exacerbation: Markedly increased ( > 40 to 50 / min > 40\text{ to }50/\text{min} > 40 to 50/ min ); Life-Threatening Exacerbation: Tachypnoea or slow, gasping respirations

Accessory Muscle Use : Mild / Moderate Exacerbation: Mild intercostal retractions; Severe Exacerbation: Marked sternal/subcostal retractions, tracheal tug; Life-Threatening Exacerbation: Paradoxical thoracoabdominal breathing

Auscultation : Mild / Moderate Exacerbation: Moderate expiratory wheezing; Severe Exacerbation: Loud, widespread expiratory and inspiratory wheeze; Life-Threatening Exacerbation: "Silent chest" (minimal/absent air entry)

  • Stepwise Emergency Management Protocol
  • 1. Inhaled Short-Acting Beta-2 Agonist (Salbutamol)

Delivery Device : Pressurised metered-dose inhaler (pMDI) connected to a valved holding chamber (spacer) (with an appropriately fitted silicone mask for children under 4 years). Spacers deliver superior pulmonary lung deposition, fewer cardiovascular side effects (less marked tachycardia), and lower hospitalisation rates compared to jet nebulisers.

Dosing Regimen :

Mild / Moderate : 2 to 6 puffs of salbutamol ( 100 mcg/puff 100\text{ mcg/puff} 100 mcg/puff ). Administer one puff at a time into the spacer, with the child taking 4 normal tidal breaths through the mouthpiece before administering the next puff. Reassess after 20 minutes.

Paediatric asthma: Follow the age-specific protocol for repeated salbutamol by pMDI/spacer, often six puffs under age six and 12 at age six or above in the acute pathway. Monitor response and consider early steroid and escalation for severe disease; IV bronchodilators require specialist monitored care.

2. Systemic Corticosteroids

Oral Prednisolone : Initiated early within the first hour of emergency presentation for all children with moderate-to-severe exacerbations.

Dose : 1 to 2 mg/kg 1\text{ to }2\text{ mg/kg} 1 to 2 mg/kg as a single oral dose (maximum single dose 50 mg 50\text{ mg} 50 mg ), continued once daily for 3 days . A 3-day course does not require dose tapering. For children unable to tolerate oral medication due to severe distress or vomiting, intravenous hydrocortisone ( 4 mg/kg 4\text{ mg/kg} 4 mg/kg 6-hourly) or methylprednisolone ( 1 mg/kg 1\text{ mg/kg} 1 mg/kg 12-hourly) is substituted.

3. Inhaled Anticholinergic (Ipratropium Bromide)

For severe or refractory acute asthma, add ipratropium bromide ( 250 mcg 250\text{ mcg} 250 mcg for children < 6 years < 6\text{ years} < 6 years , 500 mcg 500\text{ mcg} 500 mcg for children ≥ 6 years \ge 6\text{ years} ≥ 6 years ) to salbutamol nebulisation every 20 minutes for up to 3 doses during the first hour. Ipratropium blocks muscarinic receptors, promoting synergistic bronchodilation.

4. Intravenous Second-Line Therapies (Severe / Life-Threatening)

When bronchospasm is refractory to maximal inhaled bronchodilators and systemic steroids:

Intravenous Magnesium Sulfate : Administer 50 mg/kg 50\text{ mg/kg} 50 mg/kg IV (maximum 2 g 2\text{ g} 2 g ) infused over 20 minutes under continuous cardiac and blood pressure monitoring. Magnesium inhibits calcium influx into bronchial smooth muscle cells, inducing rapid relaxation.

Intravenous Salbutamol Bolus / Infusion : Loading bolus of 15 mcg/kg 15\text{ mcg/kg} 15 mcg/kg IV over 10 minutes, followed by continuous infusion at 1 to 5 mcg/kg/min 1\text{ to }5\text{ mcg/kg/min} 1 to 5 mcg/kg/min . Frequent monitoring of serum potassium is essential, as high-dose salbutamol drives potassium into cells, causing profound hypokalaemia and secondary cardiac arrhythmias.

Intravenous Aminophylline : Phosphodiesterase inhibitor reserved for PICU-level refractory status asthmaticus; requires therapeutic drug monitoring to avoid toxicity (seizures, dysrhythmias).

Reassess response rather than count puffs alone

A child who can no longer speak normally, becomes exhausted or has a quiet chest after substantial respiratory effort needs urgent escalation. Less wheeze can reflect critically reduced airflow rather than improvement. Record observations, work of breathing, air entry and response after each treatment cycle, and call senior/retrieval help early when severe. A spacer regimen is appropriate only while the child can use it effectively; respiratory failure requires another supported pathway. At discharge, review preventer use, inhaler/spacer technique, triggers, a written action plan and timely follow-up. A successful single bronchodilator dose does not settle the long-term plan.

Before discharging a child after an asthma attack, assess whether the family can use the spacer and recognise deterioration. A written action plan, appropriate preventer review and arranged follow-up address the next attack; transient improvement after salbutamol alone does not establish safe discharge.

Primary references (checked 7 October 2026): RCH croup ; 2025 Australasian bronchiolitis guideline ; ASCIA device availability .